Scholarlink

Background <p>Age &gt; 65 yrs is a risk factor for poor outcomes to influenza A virus (IAV) infection, due in part to dysregulated interferon (IFN) responses. In some models of IFN dysregulation, IFN-β administration during IAV infection improves survival and antiviral defenses. This study tested whether IFN-β administration to old mice modified disease after IAV infection without accentuating lung or brain damage.</p> Methods <p>Young (12-weeks) and old (70-weeks) male C57Bl/6&#xa0;J mice were inoculated intranasal (i.n.) with 200 PFU H1N1 A/PR/34/8 (PR8) or sterile saline. Old mice received IFN-β (2,000 U) i.n. 1d before and post-infection (p.i). Gene expression in lung and brain was measured by quantitative real time-PCR (qRT-PCR), 3d and 7d p.i. and by nCounts in whole brain, then analyzed with nSolver 4.0 and IPA® software.</p> Results <p>IFN-β treated old mice lost significantly less weight than did untreated old mice. IFN-β treatment increased the lung viral load at 3d p.i. without significantly changing the lung/body weight ratio, expression of lung inflammatory mediator genes, or histopathology of lung and brain. In contrast, brain inflammatory genes and pathways were inhibited at 3d p.i. by IFN-β but rebounded by 7d p.i. while damage-associated and some behavioral function pathways remained suppressed. TSPO, TNF, TREM2, and PIAS were possible upstream regulators of altered inflammatory and neurocognitive pathways.</p> Conclusions <p>IFN-β administration to IAV-infected old mice improved overall outcome without worsening lung damage and inhibited neuroinflammatory and brain damage-associated pathways. These results suggest IFN-β warrants further investigation as adjunctive treatment for severe viral infections in select hosts.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

IFN-β as a therapeutic agent for influenza A virus infection in old mice

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月20日

查看全文
  • Wenxin Wu,
  • Jeremy S. Alexander,
  • Yang Song,
  • J. Leland Booth,
  • Alexandra K. Ford,
  • Jordan P. Metcalf,
  • Douglas A. Drevets

摘要

Background

Age > 65 yrs is a risk factor for poor outcomes to influenza A virus (IAV) infection, due in part to dysregulated interferon (IFN) responses. In some models of IFN dysregulation, IFN-β administration during IAV infection improves survival and antiviral defenses. This study tested whether IFN-β administration to old mice modified disease after IAV infection without accentuating lung or brain damage.

Methods

Young (12-weeks) and old (70-weeks) male C57Bl/6 J mice were inoculated intranasal (i.n.) with 200 PFU H1N1 A/PR/34/8 (PR8) or sterile saline. Old mice received IFN-β (2,000 U) i.n. 1d before and post-infection (p.i). Gene expression in lung and brain was measured by quantitative real time-PCR (qRT-PCR), 3d and 7d p.i. and by nCounts in whole brain, then analyzed with nSolver 4.0 and IPA® software.

Results

IFN-β treated old mice lost significantly less weight than did untreated old mice. IFN-β treatment increased the lung viral load at 3d p.i. without significantly changing the lung/body weight ratio, expression of lung inflammatory mediator genes, or histopathology of lung and brain. In contrast, brain inflammatory genes and pathways were inhibited at 3d p.i. by IFN-β but rebounded by 7d p.i. while damage-associated and some behavioral function pathways remained suppressed. TSPO, TNF, TREM2, and PIAS were possible upstream regulators of altered inflammatory and neurocognitive pathways.

Conclusions

IFN-β administration to IAV-infected old mice improved overall outcome without worsening lung damage and inhibited neuroinflammatory and brain damage-associated pathways. These results suggest IFN-β warrants further investigation as adjunctive treatment for severe viral infections in select hosts.